COMPLEX THERAPY OF SARS AND FLU

Abstract

Respiratory viral infections of non-flu etiology – adenoviral infection, paraflu, RS-vioral infection etc. – account for the major share of SARS, up to 90%. The frequency of flu viruses infection makes up about 15% (type A – 12%, type B – 3%), paraflu viruses – up to 50%, adenoviruses – from 5 to 10%, RS-viruses – 4%, mycoplasma – 2.7%, enteroviruses – 1.2%. Combined infections make up about 23% of cases [1].

Keywords

• sars
• flu
• antiviral effect
• symptom relief